Skip to Main Content
Contribute Try STAT+ Today

Of more than 4,300 instances in which pharmacies saw generic drug prices rise by 50% or more over a recent two-year period, the reimbursement from health plans and pharmacy benefit kept up with the price increases only 16% of the time, according to a new analysis.

The findings underscore the fact that pharmacies are sometimes getting squeezed when their costs increase, which has contributed to an ongoing number of closures among retail pharmacies around the U.S. in recent years. Moreover, the numbers also suggest that consumers are more likely to find that a needed medicine, especially those where demand is rising, is no longer available.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • It takes a certain talent to take “prices are rising’ and make it something new and interesting. A “Well done” to our scribe.

Comments are closed.